UroGen Pharma Ltd. (URGN) gained 6.58% or 2.75 to $44.52. It is approximately 62823 shares traded, which is 109.08% compare to the average total volume 57594. The market cap of URGN is $705.79 million. The year to date change is 14.68%. The 52 week price range is from $25.56 to $69.57. Price of URGN have changed -7.91% during last week. It have changed -7.49% over last month, -14.76% over last 3 months, -33.40% over last 6 months and 35.84% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for URGN is 45.72. It is 2.70% above current price. The 200-day Moving Averages for URGN is 51.09. It is 14.76% above current price. The 52-week High is 69.57. It is 56.27% from the current price. The 52-week Low is 25.56. It is -42.59% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of URGN is 6.77 on 2018-09-28. Short % to float is 2.55%. There are some statistics of URGN. It is has market cap $705.79 million. The share outstanding is 15.85 million. The average volume is 57594. The revenue is 7.81M. The gross profit is 7.52M. The percent of top 15 Institution holding is 60.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of URGN is -44.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of URGN is -41.68%.